Sign In
Buy GLP
$49.26
+1.26 (+2.63%)
At Close: Jun 02, 2026
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
01:05pm, Friday, 01'st May 2026
The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals companies of all sizes are scrambling to get in on the action. For the time
Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
08:05am, Friday, 01'st May 2026
The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes The addition of Ozempic® pill will give Weight Watche
Harris Teeter Offers GLP-1 Medications, Nutrition Support and Cost-Saving Options
07:00am, Friday, 01'st May 2026
Harris Teeter supports customers navigate weight management more affordably and comfortably with nutrition support, pharmacy expertise and fresh, quality foods. MATTHEWS, N.C.
New Strong Buy Stocks for May 1st
05:55am, Friday, 01'st May 2026
GLP, STRA, FMX, SANM and SSRM have been added to the Zacks Rank #1 (Strong Buy) List on May 1, 2026.
Best Income Stocks to Buy for May 1st
05:20am, Friday, 01'st May 2026
STRA, GLP and FMX made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 1, 2026.
Best Value Stocks to Buy for May 1st
05:11am, Friday, 01'st May 2026
STRA, GLP and ENVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 1, 2026.
Eli Lilly crushes Q1 estimates, raises full-year outlook as GLP-1 sales surge
11:43am, Thursday, 30'th Apr 2026
Eli Lilly and Co (NYSE:LLY) reported stronger-than-expected first-quarter 2026 results on April 30, driven by surging demand for its diabetes and obesity treatments Mounjaro and Zepbound. Shares rose
Eli Lilly CEO on new GLP-1 pill: It's been out 20 days and we have over 20,000 patients
11:06am, Thursday, 30'th Apr 2026
More than 20,000 people have started taking Eli Lilly's GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday.
Should Value Investors Buy Global Partners (GLP) Stock?
10:40am, Thursday, 30'th Apr 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Global Partners Declares First-Quarter 2026 Cash Distribution of $0.7650 on Common Units
08:30am, Thursday, 30'th Apr 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (“Global Partners” or the “Partnership”) today announced that the Board of Directors of its general partner, Global GP LLC, has
Lilly's stock rallies as sales of GLP-1 drugs nearly double
06:58am, Thursday, 30'th Apr 2026
Sales of Mounjaro and Zepbound both beat expectations
Eli Lilly raises annual profit forecast as GLP-1 drugs fuel growth
06:51am, Thursday, 30'th Apr 2026
Eli Lilly raised its annual profit forecast and posted better-than-expected first quarter on Thursday, on steady demand for its weight-loss and diabetes drugs Zepbound and Mounjaro, in its first
Best Income Stocks to Buy for April 29th
05:31am, Wednesday, 29'th Apr 2026
GLP, BP and EGO made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 29th, 2026.
New Strong Buy Stocks for April 29th
05:25am, Wednesday, 29'th Apr 2026
DVN, EGO, GLP, MUSA and BP have been added to the Zacks Rank #1 (Strong Buy) List on April 29th, 2026.
Best Value Stocks to Buy for April 29th
04:51am, Wednesday, 29'th Apr 2026
BP, DVN and GLP made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 29th, 2026.
